glac Biotech Co., Ltd. (GTSM:6553) agreed to acquire Glory Biotech Co., Ltd. (GTSM:4187) for approximately TWD 250 million on September 18, 2017. As per the terms of transaction, glac Biotech will pay 0.4 shares for 1 shares of Glory Biotech. Post transaction Glory Biotech will be dissolved. The transaction is expected to close on November 30, 2017. As on November 28, 2017, closing date has been changed to December 29, 2017 from November 30, 2017.

glac Biotech Co., Ltd. (GTSM:6553) completed the acquisition of Glory Biotech Co., Ltd. (GTSM:4187) on December 29, 2017.